Effect of a selective inducible nitric oxide synthase inhibitor on intraocular nitric oxide production in endotoxin-induced uveitis rabbits: in vivo intraocular microdialysis study

被引:16
作者
Kamata, K
Inazu, M
Takeda, H
Goto, H
Matsumiya, T
Usui, M
机构
[1] Tokyo Med Univ, Dept Pharmacol, Shinjuku Ku, Tokyo 1608402, Japan
[2] Tokyo Med Univ, Intractable Dis Res Ctr, Shinjuku Ku, Tokyo 1608402, Japan
[3] Tokyo Med Univ, Dept Ophthalmol, Shinjuku Ku, Tokyo 1600023, Japan
关键词
nitric oxide; endotoxin-induced uveitis; inducible nitric oxide synthase; microdialysis;
D O I
10.1016/S1043-6618(03)00057-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Inducible nitric oxide (NO) synthase (iNOS) is believed to contribute to the pathogenesis of endotoxin-induced uveitis (EIU). In the present study, we investigated the inhibitory effects of N-G-nitro-L-arginine methyl ester (L-NAME), a non-selective NOS inhibitor, and S,S'-1,4-phenylene-bis(1,2-ethanediyl)bis-isothiourea (PBITU), a potent and selective iNOS inhibitor, on intraocular NO production in EIU rabbits using an in vivo intraocular microdialysis technique. The flare level in the anterior chamber increased from 1 h after the injection of 100 mug/kg lipopolysaccharide (LPS), and continued to increase for 24 h. Aqueous humor protein concentrations were significantly increased at 24 h after LPS-injection. These changes were significantly reduced by L-NAME (10 mg/kg) and PBITU (1 mg/kg), but not by D-NAME (10 mg/kg). The increase in NO2- and NO3- levels in the dialysate induced by LPS was significantly inhibited by L-NAME (10 mg/kg) and PBITU (1 mg/kg), but not by D-NAME (10 mg/kg). These results suggest that activation of iNOS may play a key role in the development of EIU, and selective inhibitors of iNOS may have therapeutic applications in the treatment of EIU. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:485 / 491
页数:7
相关论文
共 34 条
[11]  
GOUREAU O, 1995, J IMMUNOL, V154, P6518
[12]  
JAQUEMIN E, 1996, INVEST OPHTH VIS SCI, V37, P1187
[13]   NITRIC-OXIDE SYNTHASES IN MAMMALS [J].
KNOWLES, RG ;
MONCADA, S .
BIOCHEMICAL JOURNAL, 1994, 298 :249-258
[14]   Functional role of nitric oxide in regulation of ocular blood flow [J].
Koss, MC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 374 (02) :161-174
[15]  
KRONCKE KD, 1995, BIOL CHEM H-S, V376, P327
[16]   Ocular pharmacokinetics of cephalosporins using microdialysis [J].
Macha, S ;
Mitra, AK .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2001, 17 (05) :485-498
[17]   Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administration using microdialysis [J].
Macha, S ;
Mitra, AK .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (06) :670-675
[18]  
MANDAI M, 1994, INVEST OPHTH VIS SCI, V35, P3673
[19]  
Mandai M, 1996, INVEST OPHTH VIS SCI, V37, P826
[20]  
MONCADA S, 1991, PHARMACOL REV, V43, P109